The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2013-12

AUTHORS

Min S Park, Vinod Ravi, Anthony Conley, Shreyaskumar R Patel, Jonathan C Trent, Dina C Lev, Alexander J Lazar, Wei-Lien Wang, Robert S Benjamin, Dejka M Araujo

ABSTRACT

BACKGROUND: Patients with advanced solitary fibrous tumors (SFTs) have a poor prognosis; treatment options for recurrent disease are particularly limited. Several novel targeted agents have recently shown promise against advanced SFTs, but the relative efficacy of new agents is difficult to assess because data on the efficacy of conventional chemotherapy for SFTs are limited. We thus sought to estimate the efficacy of conventional chemotherapy for SFTs by reviewing data on tumor response to therapy and progression-free survival from SFT patients who received this therapy. METHODS: We retrospectively analyzed the clinical outcomes of 21 patients with grossly measurable, advanced SFTs (unresectable metastatic disease or potentially resectable primary tumors) who received conventional chemotherapy and follow-up at The University of Texas MD Anderson Cancer Center between January 1994 and June 2007. Best tumor response to therapy was assessed using the Response Evaluation Criteria In Solid Tumors 1.1. The Kaplan-Meier method was used to estimate median progression-free survival (PFS) duration. RESULTS: Of 21 patients, 4 received more than 1 regimen of chemotherapy, for a total of 25 treatments. Doxorubicin-based chemotherapy was given in 15 cases (60%), gemcitabine-based therapy in 5 cases (20%), and paclitaxel in 5 cases (20%). First-line chemotherapy was delivered in 18 cases (72%). No patients had a complete or partial response, 16 (89%) had stable disease, and 2 (11%) had disease progression. Five patients (28%) maintained stable disease for at least 6 months after first-line treatment. The median PFS duration was 4.6 months. The median overall survival from diagnosis was 10.3 years. CONCLUSION: Conventional chemotherapy is effective in controlling or stabilizing locally advanced and metastatic SFTs. Our findings can serve as a reference for tumor response and clinical outcomes in the assessment of novel treatments for SFTs. More... »

PAGES

7

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/2045-3329-3-7

DOI

http://dx.doi.org/10.1186/2045-3329-3-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1032400938

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23663788


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Sarcoma Medical Oncology Unit 0450, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 77030, Houston, TX, USA", 
            "Department of Hematology/Oncology, Minor and James Medical, PLLC, 515 Minor Avenue, 98104, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Park", 
        "givenName": "Min S", 
        "id": "sg:person.01204354567.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204354567.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Sarcoma Medical Oncology Unit 0450, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ravi", 
        "givenName": "Vinod", 
        "id": "sg:person.01252467767.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252467767.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Sarcoma Medical Oncology Unit 0450, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Conley", 
        "givenName": "Anthony", 
        "id": "sg:person.01135563761.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135563761.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Sarcoma Medical Oncology Unit 0450, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Patel", 
        "givenName": "Shreyaskumar R", 
        "id": "sg:person.013307202747.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013307202747.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Miami", 
          "id": "https://www.grid.ac/institutes/grid.26790.3a", 
          "name": [
            "Department of Sarcoma Medical Oncology Unit 0450, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 77030, Houston, TX, USA", 
            "Sarcoma Medical Oncology Program, University of Miami Sylvester Comprehensive Cancer Center, 1475 N.W. 12th Avenue, 33136, Miami, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Trent", 
        "givenName": "Jonathan C", 
        "id": "sg:person.01016450045.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016450045.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Cancer Biology and the Adult Sarcoma Research Center, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lev", 
        "givenName": "Dina C", 
        "id": "sg:person.0707247605.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707247605.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Pathology and the Adult Sarcoma Research Center, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lazar", 
        "givenName": "Alexander J", 
        "id": "sg:person.010255222337.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010255222337.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Pathology and the Adult Sarcoma Research Center, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Wei-Lien", 
        "id": "sg:person.010331373604.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010331373604.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Sarcoma Medical Oncology Unit 0450, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Benjamin", 
        "givenName": "Robert S", 
        "id": "sg:person.01200333274.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200333274.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Sarcoma Medical Oncology Unit 0450, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Araujo", 
        "givenName": "Dejka M", 
        "id": "sg:person.01171370257.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171370257.91"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0046-8177(76)80006-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000607290"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10637-009-9249-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004621655", 
          "https://doi.org/10.1007/s10637-009-9249-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10637-009-9249-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004621655", 
          "https://doi.org/10.1007/s10637-009-9249-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0046-8177(91)90067-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006394786"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2013.03.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009056160"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.26098", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013138672"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02303499", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013619459", 
          "https://doi.org/10.1007/bf02303499"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02303499", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013619459", 
          "https://doi.org/10.1007/bf02303499"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jtcvs.2009.01.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017098749"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.26334", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017209377"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-09-1205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018137286"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0046-8177(99)90169-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018817422"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.07.3411", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019062068"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.07.3049", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020547992"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2008.10.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026558254"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-10-2621", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028267822"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jso.2930220306", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033624050"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2559.2005.02290.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033633830"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2559.2005.02290.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033633830"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.10867", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038685380"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cco.0b013e32832c9532", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040830877"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cco.0b013e32832c9532", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040830877"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cco.0b013e32832c9532", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040830877"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.21.3223", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049371010"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2559.2005.02284.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051160877"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2559.2005.02284.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051160877"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1010-7940(02)00099-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054669767"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-12", 
    "datePublishedReg": "2013-12-01", 
    "description": "BACKGROUND: Patients with advanced solitary fibrous tumors (SFTs) have a poor prognosis; treatment options for recurrent disease are particularly limited. Several novel targeted agents have recently shown promise against advanced SFTs, but the relative efficacy of new agents is difficult to assess because data on the efficacy of conventional chemotherapy for SFTs are limited. We thus sought to estimate the efficacy of conventional chemotherapy for SFTs by reviewing data on tumor response to therapy and progression-free survival from SFT patients who received this therapy.\nMETHODS: We retrospectively analyzed the clinical outcomes of 21 patients with grossly measurable, advanced SFTs (unresectable metastatic disease or potentially resectable primary tumors) who received conventional chemotherapy and follow-up at The University of Texas MD Anderson Cancer Center between January 1994 and June 2007. Best tumor response to therapy was assessed using the Response Evaluation Criteria In Solid Tumors 1.1. The Kaplan-Meier method was used to estimate median progression-free survival (PFS) duration.\nRESULTS: Of 21 patients, 4 received more than 1 regimen of chemotherapy, for a total of 25 treatments. Doxorubicin-based chemotherapy was given in 15 cases (60%), gemcitabine-based therapy in 5 cases (20%), and paclitaxel in 5 cases (20%). First-line chemotherapy was delivered in 18 cases (72%). No patients had a complete or partial response, 16 (89%) had stable disease, and 2 (11%) had disease progression. Five patients (28%) maintained stable disease for at least 6 months after first-line treatment. The median PFS duration was 4.6 months. The median overall survival from diagnosis was 10.3 years.\nCONCLUSION: Conventional chemotherapy is effective in controlling or stabilizing locally advanced and metastatic SFTs. Our findings can serve as a reference for tumor response and clinical outcomes in the assessment of novel treatments for SFTs.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/2045-3329-3-7", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2438826", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1046367", 
        "issn": [
          "2045-3329"
        ], 
        "name": "Clinical Sarcoma Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "3"
      }
    ], 
    "name": "The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis", 
    "pagination": "7", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "9a5a3d7741ccf9a09d1137a0c24a1d6960606a75c789b5125e27a6fd977236e6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23663788"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101577890"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/2045-3329-3-7"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1032400938"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/2045-3329-3-7", 
      "https://app.dimensions.ai/details/publication/pub.1032400938"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:42", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000513.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F2045-3329-3-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/2045-3329-3-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/2045-3329-3-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/2045-3329-3-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/2045-3329-3-7'


 

This table displays all metadata directly associated to this object as RDF triples.

205 TRIPLES      21 PREDICATES      50 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/2045-3329-3-7 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Nb4a8eb69562c407abe5982a9d77e5d3f
4 schema:citation sg:pub.10.1007/bf02303499
5 sg:pub.10.1007/s10637-009-9249-1
6 https://doi.org/10.1002/cncr.10867
7 https://doi.org/10.1002/cncr.26098
8 https://doi.org/10.1002/cncr.26334
9 https://doi.org/10.1002/jso.2930220306
10 https://doi.org/10.1016/0046-8177(91)90067-y
11 https://doi.org/10.1016/j.ejca.2008.10.026
12 https://doi.org/10.1016/j.ejca.2013.03.017
13 https://doi.org/10.1016/j.jtcvs.2009.01.026
14 https://doi.org/10.1016/s0046-8177(76)80006-8
15 https://doi.org/10.1016/s0046-8177(99)90169-7
16 https://doi.org/10.1016/s1010-7940(02)00099-4
17 https://doi.org/10.1097/cco.0b013e32832c9532
18 https://doi.org/10.1111/j.1365-2559.2005.02284.x
19 https://doi.org/10.1111/j.1365-2559.2005.02290.x
20 https://doi.org/10.1158/1078-0432.ccr-10-2621
21 https://doi.org/10.1158/1535-7163.mct-09-1205
22 https://doi.org/10.1200/jco.2006.07.3049
23 https://doi.org/10.1200/jco.2006.07.3411
24 https://doi.org/10.1200/jco.2008.21.3223
25 schema:datePublished 2013-12
26 schema:datePublishedReg 2013-12-01
27 schema:description BACKGROUND: Patients with advanced solitary fibrous tumors (SFTs) have a poor prognosis; treatment options for recurrent disease are particularly limited. Several novel targeted agents have recently shown promise against advanced SFTs, but the relative efficacy of new agents is difficult to assess because data on the efficacy of conventional chemotherapy for SFTs are limited. We thus sought to estimate the efficacy of conventional chemotherapy for SFTs by reviewing data on tumor response to therapy and progression-free survival from SFT patients who received this therapy. METHODS: We retrospectively analyzed the clinical outcomes of 21 patients with grossly measurable, advanced SFTs (unresectable metastatic disease or potentially resectable primary tumors) who received conventional chemotherapy and follow-up at The University of Texas MD Anderson Cancer Center between January 1994 and June 2007. Best tumor response to therapy was assessed using the Response Evaluation Criteria In Solid Tumors 1.1. The Kaplan-Meier method was used to estimate median progression-free survival (PFS) duration. RESULTS: Of 21 patients, 4 received more than 1 regimen of chemotherapy, for a total of 25 treatments. Doxorubicin-based chemotherapy was given in 15 cases (60%), gemcitabine-based therapy in 5 cases (20%), and paclitaxel in 5 cases (20%). First-line chemotherapy was delivered in 18 cases (72%). No patients had a complete or partial response, 16 (89%) had stable disease, and 2 (11%) had disease progression. Five patients (28%) maintained stable disease for at least 6 months after first-line treatment. The median PFS duration was 4.6 months. The median overall survival from diagnosis was 10.3 years. CONCLUSION: Conventional chemotherapy is effective in controlling or stabilizing locally advanced and metastatic SFTs. Our findings can serve as a reference for tumor response and clinical outcomes in the assessment of novel treatments for SFTs.
28 schema:genre research_article
29 schema:inLanguage en
30 schema:isAccessibleForFree true
31 schema:isPartOf N3a46906eef8042b5ad3ea12b92636803
32 N834b46c1f93a46f885da786aa4bfe4e1
33 sg:journal.1046367
34 schema:name The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis
35 schema:pagination 7
36 schema:productId N04f2dee5641c4b179ec417134d70c01c
37 N3580ba072b6948a5bf5e6bb449ca9d81
38 N6c41c117c81841f084ff1f706e2a6abe
39 Nb852e996d3de42e08fed61de8d8ed995
40 Ne2a2b2fee703498898d4b4607a03c84a
41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032400938
42 https://doi.org/10.1186/2045-3329-3-7
43 schema:sdDatePublished 2019-04-10T16:42
44 schema:sdLicense https://scigraph.springernature.com/explorer/license/
45 schema:sdPublisher N204ecb971da1478aa401ec242e8dc909
46 schema:url http://link.springer.com/10.1186%2F2045-3329-3-7
47 sgo:license sg:explorer/license/
48 sgo:sdDataset articles
49 rdf:type schema:ScholarlyArticle
50 N04f2dee5641c4b179ec417134d70c01c schema:name pubmed_id
51 schema:value 23663788
52 rdf:type schema:PropertyValue
53 N092a2869d62a4bbcbdd7925eeca193d6 rdf:first sg:person.010331373604.53
54 rdf:rest Ne8d5fcae08d34aaab6b9c5e24aae1328
55 N204ecb971da1478aa401ec242e8dc909 schema:name Springer Nature - SN SciGraph project
56 rdf:type schema:Organization
57 N30d8161ffb6f486688f658a944c9d88f rdf:first sg:person.01016450045.91
58 rdf:rest Nfbcd8a4d891c43edad3da419f614c4ab
59 N3580ba072b6948a5bf5e6bb449ca9d81 schema:name readcube_id
60 schema:value 9a5a3d7741ccf9a09d1137a0c24a1d6960606a75c789b5125e27a6fd977236e6
61 rdf:type schema:PropertyValue
62 N3a46906eef8042b5ad3ea12b92636803 schema:issueNumber 1
63 rdf:type schema:PublicationIssue
64 N47563d8fa4014daca1a6d918660789a6 rdf:first sg:person.01135563761.22
65 rdf:rest Nf0714333353f44ad9251a3b28df5a101
66 N6931c2d89e0b4c04845b74419f48dffd rdf:first sg:person.01171370257.91
67 rdf:rest rdf:nil
68 N6c41c117c81841f084ff1f706e2a6abe schema:name nlm_unique_id
69 schema:value 101577890
70 rdf:type schema:PropertyValue
71 N834b46c1f93a46f885da786aa4bfe4e1 schema:volumeNumber 3
72 rdf:type schema:PublicationVolume
73 Nb4a8eb69562c407abe5982a9d77e5d3f rdf:first sg:person.01204354567.72
74 rdf:rest Nb7c224cf5b4f47c9ab63622170f41b8e
75 Nb7c224cf5b4f47c9ab63622170f41b8e rdf:first sg:person.01252467767.86
76 rdf:rest N47563d8fa4014daca1a6d918660789a6
77 Nb852e996d3de42e08fed61de8d8ed995 schema:name doi
78 schema:value 10.1186/2045-3329-3-7
79 rdf:type schema:PropertyValue
80 Nbfb98aa62dcf4c1a8090a435f2da7912 rdf:first sg:person.010255222337.53
81 rdf:rest N092a2869d62a4bbcbdd7925eeca193d6
82 Ne2a2b2fee703498898d4b4607a03c84a schema:name dimensions_id
83 schema:value pub.1032400938
84 rdf:type schema:PropertyValue
85 Ne8d5fcae08d34aaab6b9c5e24aae1328 rdf:first sg:person.01200333274.18
86 rdf:rest N6931c2d89e0b4c04845b74419f48dffd
87 Nf0714333353f44ad9251a3b28df5a101 rdf:first sg:person.013307202747.74
88 rdf:rest N30d8161ffb6f486688f658a944c9d88f
89 Nfbcd8a4d891c43edad3da419f614c4ab rdf:first sg:person.0707247605.98
90 rdf:rest Nbfb98aa62dcf4c1a8090a435f2da7912
91 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
92 schema:name Medical and Health Sciences
93 rdf:type schema:DefinedTerm
94 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
95 schema:name Oncology and Carcinogenesis
96 rdf:type schema:DefinedTerm
97 sg:grant.2438826 http://pending.schema.org/fundedItem sg:pub.10.1186/2045-3329-3-7
98 rdf:type schema:MonetaryGrant
99 sg:journal.1046367 schema:issn 2045-3329
100 schema:name Clinical Sarcoma Research
101 rdf:type schema:Periodical
102 sg:person.01016450045.91 schema:affiliation https://www.grid.ac/institutes/grid.26790.3a
103 schema:familyName Trent
104 schema:givenName Jonathan C
105 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016450045.91
106 rdf:type schema:Person
107 sg:person.010255222337.53 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
108 schema:familyName Lazar
109 schema:givenName Alexander J
110 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010255222337.53
111 rdf:type schema:Person
112 sg:person.010331373604.53 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
113 schema:familyName Wang
114 schema:givenName Wei-Lien
115 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010331373604.53
116 rdf:type schema:Person
117 sg:person.01135563761.22 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
118 schema:familyName Conley
119 schema:givenName Anthony
120 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135563761.22
121 rdf:type schema:Person
122 sg:person.01171370257.91 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
123 schema:familyName Araujo
124 schema:givenName Dejka M
125 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171370257.91
126 rdf:type schema:Person
127 sg:person.01200333274.18 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
128 schema:familyName Benjamin
129 schema:givenName Robert S
130 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200333274.18
131 rdf:type schema:Person
132 sg:person.01204354567.72 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
133 schema:familyName Park
134 schema:givenName Min S
135 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204354567.72
136 rdf:type schema:Person
137 sg:person.01252467767.86 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
138 schema:familyName Ravi
139 schema:givenName Vinod
140 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252467767.86
141 rdf:type schema:Person
142 sg:person.013307202747.74 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
143 schema:familyName Patel
144 schema:givenName Shreyaskumar R
145 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013307202747.74
146 rdf:type schema:Person
147 sg:person.0707247605.98 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
148 schema:familyName Lev
149 schema:givenName Dina C
150 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707247605.98
151 rdf:type schema:Person
152 sg:pub.10.1007/bf02303499 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013619459
153 https://doi.org/10.1007/bf02303499
154 rdf:type schema:CreativeWork
155 sg:pub.10.1007/s10637-009-9249-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004621655
156 https://doi.org/10.1007/s10637-009-9249-1
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1002/cncr.10867 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038685380
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1002/cncr.26098 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013138672
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1002/cncr.26334 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017209377
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1002/jso.2930220306 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033624050
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1016/0046-8177(91)90067-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1006394786
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1016/j.ejca.2008.10.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026558254
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1016/j.ejca.2013.03.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009056160
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1016/j.jtcvs.2009.01.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017098749
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1016/s0046-8177(76)80006-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000607290
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1016/s0046-8177(99)90169-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018817422
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1016/s1010-7940(02)00099-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054669767
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1097/cco.0b013e32832c9532 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040830877
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1111/j.1365-2559.2005.02284.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1051160877
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1111/j.1365-2559.2005.02290.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1033633830
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1158/1078-0432.ccr-10-2621 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028267822
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1158/1535-7163.mct-09-1205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018137286
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1200/jco.2006.07.3049 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020547992
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1200/jco.2006.07.3411 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019062068
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1200/jco.2008.21.3223 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049371010
195 rdf:type schema:CreativeWork
196 https://www.grid.ac/institutes/grid.240145.6 schema:alternateName The University of Texas MD Anderson Cancer Center
197 schema:name Department of Cancer Biology and the Adult Sarcoma Research Center, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 77030, Houston, TX, USA
198 Department of Hematology/Oncology, Minor and James Medical, PLLC, 515 Minor Avenue, 98104, Seattle, WA, USA
199 Department of Pathology and the Adult Sarcoma Research Center, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 77030, Houston, TX, USA
200 Department of Sarcoma Medical Oncology Unit 0450, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 77030, Houston, TX, USA
201 rdf:type schema:Organization
202 https://www.grid.ac/institutes/grid.26790.3a schema:alternateName University of Miami
203 schema:name Department of Sarcoma Medical Oncology Unit 0450, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 77030, Houston, TX, USA
204 Sarcoma Medical Oncology Program, University of Miami Sylvester Comprehensive Cancer Center, 1475 N.W. 12th Avenue, 33136, Miami, FL, USA
205 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...